A Leader In The Plant-Made Pharmaceutical Field
iBio, Inc. develops pharmaceutical product applications using its iBio Technology platform; a platform that has proven to be more efficient and cost-effective than traditional systems.
The iBio Technology has been validated by major industry players, as well as the Brazilian government, opening iBio’s doorway to the world market.
With extensive patent protection and proprietary know-how, iBio creates a high barrier to entry for competitors.
** $100+ million in R&D in the iBio Technology Platform **
** $646M+ iBio Total Brazilian Market Opportunity **
** 60+ issued patents in various countries, 20 U.S. **